Top three insurers reaped $7.3 billion through their drug middlemen's markups, FTC says
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
The Cigna Group's Fourth Quarter 2024 Earnings Release Details
Global health company The Cigna Group (NYSE:CI) will release its fourth quarter 2024 financial results on Thursday, January ...
FTC report shows $7.3 billion in drug price inflation by leading pharmacy benefit managers
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...
Cigna (CI) Receives a Buy from Bernstein
In a report released yesterday, Lance Wilkes from Bernstein maintained a Buy rating on Cigna (CI – Research Report), with a price target of ...
YourTango11h
Woman Who Lost Her Hand In Shark Attack Forced To Raise Money For A Prosthetic After Insurance Company Said It’s Not Medically Necessary
Elisabeth Foley, a woman who lost her hand in a brutal shark attack, is no different. Although her medical team recommended the use of a prosthetic, her health insurance company did not deem it ...
STAT2d
Cigna, Centene, Walgreens drop out of J.P. Morgan conference
Cigna and Centene were among a dozen companies that appeared on the initial JPM agenda that have bowed out of the conference.
UnitedHealth, employer of slain exec Brian Thompson, found to have overcharged some cancer patients for drugs by over 1,000%
The accused killer of Brian Thompson cited the industry’s failures as his motive for assassinating the UnitedHealth executive ...
Hosted on MSN8d
Cigna Stock Plunges 18.7% in 3 Months: Should You Buy, Hold or Sell?
Shares of The Cigna Group CI have plunged 18.7% in the past three months, underperforming the industry’s decline of 12%.
FTC Says CVS, Cigna and UnitedHealth Abuse Middleman Role (3)
Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average ...
FTC Says UnitedHealth, CVS, Cigna Make Billions Via PBMs On Specialty Drugs
FTC report reveals significant markups by top PBMs on specialty drugs, driving $7.3 billion in revenue and raising costs for ...
STAT1d
FTC slams PBMs for boosting specialty drug prices at the expense of the U.S. health care system
For the second time in less than a year, the FTC has released a highly critical report of pharmacy benefit managers, or PBMs.
Salem Health, Regence return to negotiations after 30K people lose in-network coverage
Salem Health and Regence BlueCross BlueShield of Oregon are returning to the negotiating table after almost 30,000 people ...